Medical Condition News

RSS

CPEB4 protein plays a crucial role in cancer progression

A study by researchers Ra-l M-ndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona) and Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) describes a new reprogramming mechanism for the expression of genes responsible for turning a healthy cell into a tumor cell.

5 Dec 2011

Epilepsy patients can benefit from gamma knife radiosurgery

Neurosurgeons continue to explore minimally invasive surgery with gamma radiation (gamma knife surgery / GKS) in the treatment of brain lesions causing seizures and epilepsy. Studies of the procedure are showing it to be an effective alternative to invasive microsurgery for hypothalamic hamartomas and other lesions that lie deep within the brain.

5 Dec 2011

Cancer cells can 'bag up and bin' a toxic protein to cheat death

Cancer Research UK scientists have discovered that cancer cells can 'bag up and bin' a toxic protein to cheat death - revealing a new Achilles heel in cancer cells that could be targeted for treatment, reveals research in Nature Cell Biology today.

5 Dec 2011

Study: 3D-TV may cause seizures in children and adolescents

Certain visual patterns and flashing images can provoke seizures in susceptible individuals, particularly among children and adolescents. Some media reports on the recent introduction of 3D-television sets suggest that this new technology may cause seizures in some viewers.

5 Dec 2011

Potential medical and social barriers to resective epilepsy surgery in patients after initial evaluation

Epilepsy surgery is safe, effective and often curative in selected candidates. Although candidates for epilepsy surgery in the United States are estimated between 100,000 and 200,000, fewer than 5,000 such surgeries are conducted each year. The cause of this disparity is multi-factorial, including an unexplained low level of referrals by physicians and choices made by patients themselves.

5 Dec 2011

Hypothalamus may be involved in generating laughter

Anecdotal evidence suggests that the hypothalamus, a structure lying deep within the brain may be involved in generating laughter. Gelastic epilepsy, a rare condition characterized by laughing seizures, is commonly the result of a congenital brain lesion within the hypothalamus.

5 Dec 2011

Researchers uncover binding pocket of 'functional significance' in Ras oncoprotein

A drug discovery team at Genentech, Inc., has uncovered a chink in the molecular armor of Ras, the most commonly occurring oncogene, which is a gene that when mutated has the potential of causing cancer in humans.

5 Dec 2011

Bromide shows promise against SCN1A-associated Dravet syndrome with intractable seizures

In the mid-nineteenth century Charles Locock, physician to Queen Victoria, introduced bromide as the first effective treatment for epilepsy. The drug was little used in treating the disorder until 1868, however, when its efficacy against seizures was first demonstrated in a clinical trial. Bromide was the sole anticonvulsant available until 1912 and the introduction of phenobarbital.

5 Dec 2011

Post-baseline vision data from Lundbeck's Sabril patient registry presented at AES meeting

Post-baseline vision data from Lundbeck's Sabril patient registry is available for the first time today as a late-breaking poster presentation at the annual meeting of the American Epilepsy Society.

5 Dec 2011

Vejthani Hospital offers Computer Assisted Replacement Surgery on knee arthroplasty

Vejthani Hospital Bangkok offers Computer Assisted Replacement Surgery on knee arthroplasty, the intelligent medical surgery software at TJR Center of Vejthani Hospital.

3 Dec 2011

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.

3 Dec 2011

HRF inhibitors may provide new therapeutic avenue for treatment of asthma and allergies

La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.

3 Dec 2011

La Jolla researchers create first cellular movies showing destruction underlying type 1 diabetes

A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now.

3 Dec 2011

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

Shire plc, the global specialty biopharmaceutical company, announces that it has reached an agreement with the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration to conduct additional clinical trials to confirm the clinical benefit of ProAmatine (midodrine HCl), a medicine approved in 1996 under Subpart H for the treatment of symptomatic orthostatic hypotension (SOH).

3 Dec 2011

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Novocure, a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the U.S. will be the first to provide access to its Tumor Treating Fields (TTFields) device, NovoTTF-100A System, for the treatment of recurrent glioblastoma multiforme. GBM is a deadly brain tumor affecting approximately 10,000 Americans each year.

3 Dec 2011

Mainz gastroenterologist awarded ERC Advanced Grant

The European Research Council (ERC) has earmarked about €2.5 mio. to fund the research being conducted by gastroenterologist and biochemist Professor Dr. Dr. Detlef Schuppan at Mainz University Medical Center.

3 Dec 2011

NASA-developed technology for treatment of hardened arteries in the heart

NASA has signed a patent license agreement that will allow a California company use of NASA-developed technology that could be used to treat hardened arteries in the heart.

3 Dec 2011

American Plasma Users Coalition awarded $40,000 advocacy grant from CSL Behring

CSL Behring announced today that it has awarded a $40,000 advocacy grant to the American Plasma Users Coalition (A-PLUS) through its Local Empowerment for Advocacy Development (LEAD) program. LEAD grants support the grassroots advocacy efforts of organizations that help people who use plasma-derived or recombinant therapies to manage rare and serious medical disorders.

3 Dec 2011

World Cell Race pulls 70 entries for title of world's fastest cell

A "team" of fast-moving, bone marrow stem cells from a research laboratory in Singapore has run away with the first World Cell Race, finishing first with a cellular speed record of 5.2 microns per minute (or 0.000204 inches per minute) in results announced today at the 51st Annual Meeting of the American Society for Cell Biology (ASCB).

3 Dec 2011

Study identifies sulfomucins as potential targets for therapies to treat chronic intestinal inflammatory disorders

In a paper published in the December 2011 issue of Experimental Biology and Medicine, a team of scientists at the University of Illinois, Urbana-Champaign led by Rex Gaskins, PhD have demonstrated that both microbial and host inflammatory factors modulate sulfomucin production in a human cell line, LS174T, that models intestinal goblet cells.

3 Dec 2011

Medical Condition News

CPEB4 protein plays a crucial role in cancer progression

Epilepsy patients can benefit from gamma knife radiosurgery

Cancer cells can 'bag up and bin' a toxic protein to cheat death

Study: 3D-TV may cause seizures in children and adolescents

Potential medical and social barriers to resective epilepsy surgery in patients after initial evaluation

Hypothalamus may be involved in generating laughter

Researchers uncover binding pocket of 'functional significance' in Ras oncoprotein

Bromide shows promise against SCN1A-associated Dravet syndrome with intractable seizures

Post-baseline vision data from Lundbeck's Sabril patient registry presented at AES meeting

Vejthani Hospital offers Computer Assisted Replacement Surgery on knee arthroplasty

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

HRF inhibitors may provide new therapeutic avenue for treatment of asthma and allergies

La Jolla researchers create first cellular movies showing destruction underlying type 1 diabetes

CDER, Shire enter agreement for ProAmatine clinical trial to treat symptomatic orthostatic hypotension

Four clinical centers to provide NovoTTF device treatment for recurrent GBM

Mainz gastroenterologist awarded ERC Advanced Grant

NASA-developed technology for treatment of hardened arteries in the heart

American Plasma Users Coalition awarded $40,000 advocacy grant from CSL Behring

World Cell Race pulls 70 entries for title of world's fastest cell

Study identifies sulfomucins as potential targets for therapies to treat chronic intestinal inflammatory disorders

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Latest News